scout
|Videos|June 13, 2017

Efficacy and Safety Results for Pembrolizumab in Previously Treated Gastric Cancer

Charles S. Fuchs, MD, MPH, professor of Medicine, director, Yale Cancer Center, and physician-in-chief, Smilow Cancer Hospital, discusses efficacy and safety results for pembrolizumab (Keytruda) monotherapy in patients with previously treated advanced gastric cancer.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME